製药业RFID市场－全球产业规模、份额、趋势、机会、预测：按组件、类型、应用、最终用户、地区和竞争格局划分，2021-2031年

全球医药RFID市场预计将从2025年的59.7亿美元成长到2031年的92.7亿美元，复合年增长率为7.61%。

无线射频识别 (RFID) 技术利用电磁场，能够自动识别和追踪贴附在药品包装上的标籤，从而确保产品真伪鑑别和库存可视性。这项市场成长的主要驱动力是迫切的需求，例如防止假药氾滥、提升病患安全标准以及遵守《药品供应链安全法案》(DSCSA) 等严格的监管要求。产业规模的数据也印证了这项技术的广泛应用。 RAIN 联盟在 2025 年发布的报告显示，上年度全球共出货 528 亿个 RAIN RFID 标籤晶片，而製药业被认为是这一成长的主要驱动力。

儘管存在这些市场驱动因素，但实施所需的大量资本投入仍然是限制市场整体成长的主要障碍。 RFID基础设施的全面部署涉及硬体采购、软体整合和持续系统维护等方面的巨额成本，这往往对小规模的经销商和製造商构成重大阻碍。此外，金属和液体医疗产品对讯号的干扰等技术难题通常需要专门且昂贵的技术解决方案，这可能会阻碍RFID技术在全球供应链中的广泛应用。

市场驱动因素

各国政府对药品可追溯性的严格监管是推动全球医药RFID市场发展的主要动力。世界各地的监管机构都在实施严格的单元级序列化标准，以保护药品供应链，其中美国的《药品供应链安全法案》（DSCSA）就是一个典型的例子。这些法规要求製造商过渡到无线射频识别（RFID）技术，该技术相比条码具有更优越的效能，尤其是在批量扫描和非直接资料撷取方面。根据密西根州立大学Axia研究所于2024年10月发布的《医药端到端RFID试点第二阶段》报告，RAIN RFID技术的应用已在模拟的真实环境中实现了100%的供应链可追溯性。这提供了从生产到分发，对每个单元进行身份验证和追踪所需的详细可视性。

优化医院和药房的库存管理正在加速市场成长，因为它满足了减少错误和提高营运效率的迫切需求。人工库存管理流程耗时费力，且容易出错，可能危及病人安全，而RFID技术可以自动完成这些任务，并能即时核实急救车和药品包。艾利丹尼森公司于2024年1月发表的报导《RFID产业为机会之年做好准备》的文章指出，采用RFID技术可使企业实现99.9%的库存准确率，并显着减少过期废弃物和缺货。这种自动化趋势与更广泛的行业趋势相符。根据斑马技术公司于2024年6月发布的《2024年製造业愿景调查》，92%的全球製造业领导者正在优先考虑数位转型，以增强数据可见度和控制力，医疗机构也在加速整合RFID技术以实现库存系统的现代化。

市场挑战

全球医药产业RFID市场扩张面临的主要障碍之一是高昂的实施成本。建置完整的RFID基础设施需要大量前期投资，用于购买先进的天线和读写器等硬体元件，以及整合资料管理所需的复杂软体系统。对于预算有限的中小型经销商和製造商而言，这些成本往往超过其即时营运效益，迫使他们依赖条码等成本更低的传统追踪方式。因此，这一财务障碍有效地阻碍了相当一部分供应链采用这项技术，从而抑制了市场的整体成长潜力。

近期医疗保健行业采用率的统计数据清楚地表明，人们对采用高成本技术持谨慎态度。根据美国医疗保健系统药剂师协会 (ASHP) 2024 年的数据，仅有 22.3% 的医院在其运作中应用了 RFID 标籤。这项统计数据表明，儘管对安全性和合规性的需求日益增长，但实施 RFID 技术带来的经济负担仍然显着限制了其市场渗透率，阻碍了 RFID 技术成为製药业的通用标准解决方案。

市场趋势

在医疗机构中，采用RFID技术的智慧冷藏库和药柜正迅速从简单的库存管理方法演变为采购自动化和缓解药品短缺的战略机制。医疗机构越来越依赖这些智慧储存解决方案，它们能够提供库存水准的即时可见性，从而透过简化的采购流程应对供应链中断和价格上涨。这种向自动化库存弹性的转变得益于相关数位基础设施的快速普及。根据Bluesight于2024年4月发布的《医院药房运营报告》，旨在优化高度依赖详细库存数据的药房采购工作流程的软体解决方案的采用率从上年的8%飙升至2024年的25%。

同时，温度敏感型RFID标籤在低温运输物流中的应用正在重塑市场格局，其核心在于优先考虑即时状态监测而非简单的位置追踪。随着製药业对疫苗和温度生物製药的依赖性日益增强，製造商正利用先进的RFID感测器持续记录环境数据，以确保零浪费合规并防止劣化。这种对先进品质保证的需求正推动该领域技术供应商实现显着的商业性成长。根据Controlant于2024年5月发布的“2024年度会议报告”，其核心业务——面向製药低温运输的即时可视化解决方案——的收入同比增长了79%。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球医药产业RFID市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按组件（RFID标籤、 RFID读取器）
  • 按类型（带晶片的RFID、不含晶片的RFID）
  • 依应用领域（药品追踪系统、药品品管等）
  • 依最终用户（製药公司、医院/诊所、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美製药业RFID市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲製药业RFID市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区医药产业RFID市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲製药业RFID市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲製药业RFID市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球医药产业RFID市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Zebra Technologies Corp.
• CCL Healthcare（CCL Industries Inc.）
• Fresenius Kabi AG
• Avery Dennison Corporation
• Impinj Inc.
• Bluesight, Inc.
• Terso Solutions Inc.
• GAO RFID Inc.
• Tageos SASU
• Alien Technology, Corp.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global RFID in Pharmaceuticals Market is projected to expand from USD 5.97 Billion in 2025 to USD 9.27 Billion by 2031, registering a CAGR of 7.61%. Utilizing electromagnetic fields, Radio Frequency Identification (RFID) technology allows for the automatic identification and tracking of tags affixed to medication packaging, thereby guaranteeing accurate product authentication and inventory visibility. This market growth is chiefly fueled by the urgent necessity to prevent counterfeit drugs, improve patient safety standards, and adhere to strict regulatory requirements like the Drug Supply Chain Security Act. Evidence of this rising adoption is highlighted by industrial volume data; the RAIN Alliance reported in 2025 that 52.8 billion RAIN RFID tag chips were shipped globally the previous year, with the pharmaceutical industry recognized as a significant driver of this increase.

Despite these drivers, widespread market growth faces a major obstacle due to the substantial capital investment needed for implementation. The full-scale deployment of RFID infrastructure entails significant expenses related to hardware acquisition, software integration, and ongoing system maintenance, which often discourages smaller distributors and manufacturers. Additionally, technical difficulties involving signal interference with metallic or liquid medical products frequently require specialized and expensive engineering remedies, which can potentially hinder universal adoption throughout the global supply chain.

Market Driver

The enforcement of strict government mandates for track-and-trace capabilities serves as the primary catalyst for the Global RFID in Pharmaceuticals Market. Across the globe, regulatory authorities are implementing rigorous unit-level serialization standards to safeguard the drug supply chain, with the Drug Supply Chain Security Act (DSCSA) in the United States being a prominent example. These regulations necessitate that manufacturers transition to Radio Frequency Identification (RFID) as it offers superior capabilities compared to barcodes, specifically regarding bulk scanning and non-line-of-sight data capture. As reported by the Axia Institute at Michigan State University in their October 2024 'Pharma End-to-End RFID Pilot Phase 2' report, the implementation of RAIN RFID technology allowed the supply chain to realize 100% traceability in a simulated real-world setting, providing the granular visibility needed to authenticate and track every unit from manufacturing to dispensing.

Market growth is further accelerated by the optimization of inventory management within hospitals and pharmacies, which addresses the urgent need to reduce errors and enhance operational efficiency. Manual inventory procedures are labor-intensive and susceptible to inaccuracies that may endanger patient safety; conversely, RFID automates these tasks, enabling immediate verification of crash carts and medication kits. In an article titled 'RFID Industry Prepares for a Year of Opportunities' published by Avery Dennison in January 2024, it was noted that adopting RFID technology allows organizations to reach 99.9 percent inventory accuracy, significantly decreasing expiry waste and stockouts. This push toward automation aligns with a wider industrial trend; according to the '2024 Manufacturing Vision Study' by Zebra Technologies in June 2024, 92% of global manufacturing leaders are prioritizing digital transformation to enhance data visibility and management, leading healthcare institutions to increasingly integrate RFID to modernize their inventory systems.

Market Challenge

A significant barrier hindering the broader expansion of the global RFID in pharmaceuticals market is the high capital investment necessary for implementation. Developing a complete RFID infrastructure requires substantial upfront spending on hardware components, such as sophisticated antennas and readers, along with the integration of intricate software systems essential for data management. For smaller distributors and manufacturers operating with restricted budgets, these expenses frequently exceed the immediate operational advantages, compelling them to depend on more affordable, traditional tracking methods like barcodes. Consequently, this financial obstacle effectively prevents a considerable portion of the supply chain from adopting the technology, thereby slowing the overall growth potential of the market.

The reluctance to adopt high-cost technology is clearly demonstrated by recent industry statistics concerning utilization rates in healthcare environments. Data from the American Society of Health-System Pharmacists (ASHP) in 2024 reveals that only 22.3% of hospitals had incorporated RFID tags into their operations. This statistic suggests that, despite the impetus for safety and regulatory compliance, the economic burdens associated with deployment continue to significantly limit market penetration, preventing RFID from establishing itself as a universally standard solution within the pharmaceutical sector.

Market Trends

The utilization of RFID-enabled smart refrigerators and cabinets in hospitals is rapidly advancing from a simple inventory counting method to a strategic mechanism for automating procurement and mitigating drug shortages. Healthcare facilities are increasingly depending on these intelligent storage solutions to acquire real-time visibility into stock levels, allowing them to manage supply chain disruptions and inflation by streamlining purchasing processes. This transition toward automated inventory resilience is supported by the fast adoption of related digital infrastructure; as reported by Bluesight in the April 2024 'Hospital Pharmacy Operations Report', the adoption rate of software solutions aimed at optimizing pharmacy purchasing workflows-which depend heavily on granular inventory data-rose sharply to 25% in 2024, a significant increase from just 8% the prior year.

Concurrently, the integration of temperature-sensing RFID tags within cold chain logistics is reshaping the market by placing a higher priority on real-time condition monitoring than on simple location tracking. As the pharmaceutical sector relies more heavily on vaccines and temperature-sensitive biologics, manufacturers are utilizing advanced RFID sensors that continuously record environmental data to ensure zero-waste compliance and prevent spoilage. This requirement for sophisticated quality assurance is fueling significant commercial growth for technology providers in this sector; according to the 'Annual General Meeting 2024' release by Controlant in May 2024, revenue from their core business, offering real-time visibility solutions for the pharmaceutical cold chain, increased by 79% year-over-year.

Key Market Players

• Zebra Technologies Corp.
• CCL Healthcare (CCL Industries Inc.)
• Fresenius Kabi AG
• Avery Dennison Corporation
• Impinj Inc.
• Bluesight, Inc.
• Terso Solutions Inc.
• GAO RFID Inc.
• Tageos SASU
• Alien Technology, Corp.

Report Scope

In this report, the Global RFID In Pharmaceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

RFID In Pharmaceuticals Market, By Component

• RFID Tag
• RFID Readers

RFID In Pharmaceuticals Market, By Type

• Chipped RFID
• Chipless RFID

RFID In Pharmaceuticals Market, By Application

• Drug Track & Tracing Systems
• Drug Quality Management
• Others

RFID In Pharmaceuticals Market, By End-User

• Drug Manufacturers
• Hospitals & Clinics
• Others

RFID In Pharmaceuticals Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global RFID In Pharmaceuticals Market.

Available Customizations:

Global RFID In Pharmaceuticals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global RFID In Pharmaceuticals Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (RFID Tag, RFID Readers)
  • 5.2.2. By Type (Chipped RFID, Chipless RFID)
  • 5.2.3. By Application (Drug Track & Tracing Systems, Drug Quality Management, Others)
  • 5.2.4. By End-User (Drug Manufacturers, Hospitals & Clinics, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America RFID In Pharmaceuticals Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End-User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States RFID In Pharmaceuticals Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End-User
  • 6.3.2. Canada RFID In Pharmaceuticals Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End-User
  • 6.3.3. Mexico RFID In Pharmaceuticals Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End-User

7. Europe RFID In Pharmaceuticals Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End-User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany RFID In Pharmaceuticals Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End-User
  • 7.3.2. France RFID In Pharmaceuticals Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End-User
  • 7.3.3. United Kingdom RFID In Pharmaceuticals Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End-User
  • 7.3.4. Italy RFID In Pharmaceuticals Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End-User
  • 7.3.5. Spain RFID In Pharmaceuticals Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End-User

8. Asia Pacific RFID In Pharmaceuticals Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End-User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China RFID In Pharmaceuticals Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End-User
  • 8.3.2. India RFID In Pharmaceuticals Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End-User
  • 8.3.3. Japan RFID In Pharmaceuticals Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End-User
  • 8.3.4. South Korea RFID In Pharmaceuticals Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End-User
  • 8.3.5. Australia RFID In Pharmaceuticals Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End-User

9. Middle East & Africa RFID In Pharmaceuticals Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End-User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia RFID In Pharmaceuticals Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End-User
  • 9.3.2. UAE RFID In Pharmaceuticals Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End-User
  • 9.3.3. South Africa RFID In Pharmaceuticals Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End-User

10. South America RFID In Pharmaceuticals Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End-User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil RFID In Pharmaceuticals Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End-User
  • 10.3.2. Colombia RFID In Pharmaceuticals Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End-User
  • 10.3.3. Argentina RFID In Pharmaceuticals Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global RFID In Pharmaceuticals Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Zebra Technologies Corp.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. CCL Healthcare (CCL Industries Inc.)
• 15.3. Fresenius Kabi AG
• 15.4. Avery Dennison Corporation
• 15.5. Impinj Inc.
• 15.6. Bluesight, Inc.
• 15.7. Terso Solutions Inc.
• 15.8. GAO RFID Inc.
• 15.9. Tageos SASU
• 15.10. Alien Technology, Corp.

16. Strategic Recommendations

17. About Us & Disclaimer